Frontiers in Genetics (Mar 2023)

Menkes disease complicated by concurrent ACY1 deficiency: A case report

  • Alessia Mauri,
  • Alessia Mauri,
  • Laura Assunta Saielli,
  • Enrico Alfei,
  • Maria Iascone,
  • Daniela Marchetti,
  • Elisa Cattaneo,
  • Anna Di Lauro,
  • Laura Antonelli,
  • Luisella Alberti,
  • Eleonora Bonaventura,
  • Pierangelo Veggiotti,
  • Pierangelo Veggiotti,
  • Luigina Spaccini,
  • Cristina Cereda

DOI
https://doi.org/10.3389/fgene.2023.1077625
Journal volume & issue
Vol. 14

Abstract

Read online

Introduction: Menkes disease is an X‐linked recessive condition caused by mutations in the ATP7A gene, which leads to severe copper deficiency. Aminoacylase-1 deficiency is a rare inborn error of metabolism caused by homozygous or compound heterozygous variant in the ACY1 gene, characterized by increased urinary excretion of specific N-acetyl amino acids.Case presentation: We report an infant with neurological findings such as seizures, neurodevelopmental delay and hypotonia. Metabolic screening showed low serum copper and ceruloplasmin, and increased urinary excretion of several N-acetylated amino acids. Whole-exome sequencing analysis (WES) revealed the novel de novo variant c.3642_3649dup (p.Ala1217Aspfs*2) in the ATP7A gene, leading to a diagnosis of Menkes disease, and the simultaneous presence of the homozygous ACY1 variant c.1057C>T (p.Arg353Cys) causative of Aminoacylase-1 deficiency.Conclusion: Our patient had two rare conditions with different treatment courses but overlapping clinical features. The identified novel ATP7A mutation associated with Menkes disease expands the ATP7A gene spectrum.

Keywords